AAAAAA

   
Results: 1-7 |
Results: 7
Synergistic induction of apoptosis in human leukemia cells (U937) exposed to bryostatin 1 and the proteasome inhibitor lactacystin involves dysregulation of the PKC/MAPK cascade
Authors: Vrana, JA Grant, S
Citation: Ja. Vrana et S. Grant, Synergistic induction of apoptosis in human leukemia cells (U937) exposed to bryostatin 1 and the proteasome inhibitor lactacystin involves dysregulation of the PKC/MAPK cascade, BLOOD, 97(7), 2001, pp. 2105-2114
Inhibition of the mitogen activated protein kinase pathway potentiates radiation-induced cell killing via cell cycle arrest at the G(2)/M transition and independently of increased signaling by the JNK/c-Jun pathway
Authors: Cartee, L Vrana, JA Wang, ZL Park, JS Birrer, M Fisher, PB Grant, S Dent, P
Citation: L. Cartee et al., Inhibition of the mitogen activated protein kinase pathway potentiates radiation-induced cell killing via cell cycle arrest at the G(2)/M transition and independently of increased signaling by the JNK/c-Jun pathway, INT J ONCOL, 16(2), 2000, pp. 413-422
Altered sensitivity to single-strand-specific reagents associated with thegenomic vascular smooth muscle alpha-actin promoter during myofibroblast differentiation
Authors: Becker, NA Kelm, RJ Vrana, JA Getz, MJ Maher, LJ
Citation: Na. Becker et al., Altered sensitivity to single-strand-specific reagents associated with thegenomic vascular smooth muscle alpha-actin promoter during myofibroblast differentiation, J BIOL CHEM, 275(20), 2000, pp. 15384-15391
Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-X-L, c-Jun, and p21(CIP1), but independent of p53
Authors: Vrana, JA Decker, RH Johnson, CR Wang, Z Jarvis, WD Richon, VM Ehinger, M Fisher, PB Grant, S
Citation: Ja. Vrana et al., Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-X-L, c-Jun, and p21(CIP1), but independent of p53, ONCOGENE, 18(50), 1999, pp. 7016-7025
Induction of apoptosis and differentiation by fludarabine in human leukemia cells (U937): interactions with the macrocyclic lactone bryostatin 1
Authors: Vrana, JA Wang, Z Rao, AS Tang, L Chen, JH Kramer, LB Grant, S
Citation: Ja. Vrana et al., Induction of apoptosis and differentiation by fludarabine in human leukemia cells (U937): interactions with the macrocyclic lactone bryostatin 1, LEUKEMIA, 13(7), 1999, pp. 1046-1055
Inhibition of the MAPK pathway abrogates BCL2-mediated survival of leukemia cells after exposure to low-dose ionizing radiation
Authors: Vrana, JA Grant, S Dent, P
Citation: Ja. Vrana et al., Inhibition of the MAPK pathway abrogates BCL2-mediated survival of leukemia cells after exposure to low-dose ionizing radiation, RADIAT RES, 151(5), 1999, pp. 559-569
Inhibition of protein kinase C activator-mediated induction of p21(CIP1) and p27(KIP1) by deoxycytidine analogs in human leukemia cells - Relationship to apoptosis and differentiation
Authors: Vrana, JA Kramer, LB Saunders, AM Zhang, XF Dent, P Povirk, LF Grant, S
Citation: Ja. Vrana et al., Inhibition of protein kinase C activator-mediated induction of p21(CIP1) and p27(KIP1) by deoxycytidine analogs in human leukemia cells - Relationship to apoptosis and differentiation, BIOCH PHARM, 58(1), 1999, pp. 121-131
Risultati: 1-7 |